Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Hold
2,223
0.08% 51
2026
Q1
$267K Buy
2,223
+120
+6% +$13.9K 0.07% 44
2025
Q4
$221K Buy
+2,103
New +$197K 0.06% 43
2025
Q2
Sell
-1,668
Closed -$150K 68
2025
Q1
$150K Hold
1,668
0.06% 43
2024
Q4
$166K Buy
1,668
+556
+50% +$57.3K 0.06% 44
2024
Q3
$126K Buy
1,112
+315
+40% +$37.4K 0.05% 49
2024
Q2
$142K Buy
+797
New +$103K 0.05% 46

Other funds holding MRK

Promethos Capital's MRK Position: Q2 2026 in Review

Promethos Capital held its Merck (MRK) position steady in Q2 2026 at 2,223 shares worth $286K. The position accounts for 0.08% of the portfolio, ranked #51.

Promethos Capital first reported a position in MRK in Q2 2024 and has held it in 7 quarters since. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Promethos Capital held 2,223 shares of Merck worth $286K as of Q2 2026.
  • Promethos Capital left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.08% of Promethos Capital's portfolio in Q2 2026, its #51 holding.
  • Promethos Capital first reported a position in Merck in Q2 2024 and has held it in 7 quarters since.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Promethos Capital's 13F filing for Q2 2026, filed 12 Aug 2026.